Killing is triggered by recognition of CD19, not HLA-B. The engineered STAR T cells bind CD19 and induce perforin/granzyme-mediated cytolysis; HLA-B is knocked out on the therapeutic T cells to reduce allorecognition, not to kill HLA-B–expressing cells.